The largest database of trusted experimental protocols
> Living Beings > Virus > Picornaviridae

Picornaviridae

Picornaviridae is a family of small, nonenveloped, positive-sense, single-stranded RNA viruses that infect a wide range of host species, including humans, animals, and plants.
This diverse family includes well-known pathogens such as poliovirus, rhinovirus, and hepatitis A virus.
Picornaviruses are responsible for a variety of diseases, including poliomyelitis, common cold, and hand, foot, and mouth disease.
Understanding the biology and epidemiology of this important viral family is crucial for developing effective diagnostic tools, therapies, and preventive measures.
Reseachers can leverag the power of PubCompare.ai's AI-driven platform to optimize their Picornaviridae research, locating protocols from literature, preprints, and patents, and using the AI-powered comparisons to identify the best protocols and products for enhanced reproducibility and streamlined workflowa.

Most cited protocols related to «Picornaviridae»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
Adsorption Alphacoronavirus Aluminum Chloride Beef Centrifugation Coronaviridae Diarrhea Epidemics Family Member Hydroxide, Aluminum Mengovirus Picornaviridae Pigs Porcine epidemic diarrhea virus Strains Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2007
Adenoviruses Allergens Alternaria Aspergillus Asthma Birth Cohort Child Chlamydophila pneumoniae Coronavirus 229E, Human Cough Dander Dermatophagoides pteronyssinus ECHO protocol Eczema Egg White Enterovirus Fever Fever, Hay Freezing Histamine Human Metapneumovirus Influenza Lolium Milk, Cow's Mycoplasma pneumoniae Nasopharynx Normal Saline Para-Influenza Virus Type 1 Para-Influenza Virus Type 3 Parent Physicians Picornaviridae Reverse Transcriptase Polymerase Chain Reaction Rhinorrhea Rhinovirus Saline Solution Signs and Symptoms, Respiratory Specimen Collection Test, Skin Wheezing

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Adenovirus Infections Asthma Bacteria Birth Cohort Chest Coronavirus Infections Ethics Committees Human Metapneumovirus Infant Influenza Parainfluenza Picornaviridae Respiratory Tract Infections RNA, Ribosomal, 16S Upper Respiratory Infections Virus Wheezing
Based on the results of the preliminary experiments 1 and 2 (Preliminary Experiments S1), a more extensive IAPV inoculation experiment was designed to study the time line of infection and associated gene expression patterns, and to assess bees for variability in IAPV susceptibility.
One microliter of the inoculant (PBS as control or virus solution containing 104 genome equivalents of IAPV) was injected using a NanoJet™ syringe pump (Chemix, USA) with an infusion flow rate of 0.1µl/sec, following manufacturer’s parameters. The needle was inserted in the lateral abdomen between the fourth and fifth tergite of young, white-eye honey bee pupae (Figure 2A).
Two strong, IAPV-free hives were selected from the UNCG research apiary, representing two distinct sources of bees for the experiment. From each hive, 200 white-eye pupae were collected for each of the following treatment groups: without inoculation (W/O), PBS inoculated (PBS), and IAPV inoculated (IAPV). From each treatment group and hive, 50 bees were frozen at 0 h, 5 h, 20 h and 48 h after inoculation and a subset of these samples was individually analyzed for viral titers and gene expression patterns. The first time point directly after inoculation was used as a control of the initial states of the bees in the experimental and control groups. The time point of five hours post-infection was chosen to measure the virus impact before completion of the replication cycle, based on the assumption that IAPV follows the picornavirus family average timing for a replication cycle, of 7–12 hours [32] , [34] (link), [35] (link). Any gene expression changes at this time point represent the bees’ response to inoculation without complications from virus-related tissue damage. The time point of 20 h post-infection was considered representative of events after one complete cycle of virus replication, and the 48 h time point represents the established diseased state, characterized by visual symptoms.
Based on the results of the preliminary experiments (Preliminary Experiments S1), we tested the effect of IAPV injection on gene expression of six commonly used reference genes that have been reported to be constantly expressed across different experimental conditions [4] (link), [7] (link), [41] (link). We studied the transcription of Actin, ribosomal 28S RNA, ribosomal 18S RNA, ribosomal protein RPS5, MGST1, and Histone H2A, under IAPV infection. Histone H2A is not common used in honey bees, but it was added to our experiment because its expression is constitutive and cell-cycle independent, and it is commonly used on other models [42] (link). The sequences of utilized H2A primers are: 5′-AAAGGAAATTACGCAGAACGA-3′ (H2A Forward) and 5′-CGGCTAAATATTCCATAACGG-3′ (H2A Reverse). In addition, the titers of IAPV and DWV were quantified in these samples.
Full text: Click here
Publication 2013
Abdomen Actins Bees Cell Cycle Freezing Gene Expression Genes Genome Honey Infection Needles Oligonucleotide Primers Picornaviridae Pupa Ribosomal Proteins Ribosomal RNA Sclera Susceptibility, Disease Syringes TimeLine Tissues Training Programs Transcription, Genetic Urticaria Vaccination Virus Virus Replication
In addition to the green fluorescent protein (GFP) reporter virus that measures the number of cells in which the latent HIV provirus is successfully reactivated, we created a luciferase-expressing virus that measures overall levels of transcriptional reactivation of latent HIV. A fully infectious molecular clone of NL4-3 expressing firefly luciferase from the native LTR was prepared, essentially as described below,for the replication-defective pseudotyping vector pNL-Luc-ER. Both pNL-Luc-ER and the fully infectious molecular clone, pNL4-3, were obtained from the AIDS Research and Reference Reagent Program. pNL-Luc-ER was originally generated by transposition of the firefly luciferase gene from the molecular clone pHXB-Luc [28] (link) into pNL4-3 between the BamHI (nt 8021) and XhoI sites (nt 8443) within the nef coding region [29] (link). The BamHI-XhoI fragment of pNL-Luc-ER was shuttled into pNL4-3 to yield an env+/vpr+ vector that, when transfected, produces viruses capable of multiple rounds of infection and luciferase driven from the viral LTR. We also prepared an HIV dual reporter vector expressing mCherry and luciferase to simultaneously measure the number of cells containing reactivated latent provirus and the overall strength of the viral transcriptional response in these cells. To generate a fully infectious molecular clone expressing both of these reporters, firefly luciferase was inserted in place of the puromycin resistance gene in a modified pSicoR lentiviral expression vector termed pSicoRMS2 (a kind gift of Matt Spindler and Bruce Conklin, Gladstone Institute of Cardiovascular Disease). This vector contains an EF-1 alpha–driven mCherry:Puromycin cassette in which mCherry and puromycin are separated by a picornavirus-derived ribosomal skipping T2A sequence. The T2A sequence (ccccgggagggcagaggaagtcttctaacatgcggtgacgtggaggagaatcccggccctcga) allows balanced production of the two flanking gene products [30] (link), [31] (link). The firefly luciferase gene was subcloned in place of puromycin with XmaI and EcoRI. Clones were then tested for mCherry and luciferase expression after transfection of 293T cells. Mcherry:T2A:luciferase was amplified using PCR primers containing 5′ and 3′ sequences from the pNLENG1 vector (NL4-3 GFP). This amplicon was digested with BamHI and SalI and inserted into the pNLENG1 vector backbone at the unique BamHI and XhoI sites. The XhoI site was destroyed in the cloning process, resulting in an S34C mutation in Nef.
Full text: Click here
Publication 2012
Acquired Immunodeficiency Syndrome Cardiovascular Diseases Cells Cloning Vectors Deoxyribonuclease EcoRI DNA Replication Elongation Factor 1alpha Genes Green Fluorescent Proteins HEK293 Cells Infection Luciferases Luciferases, Firefly Mutation Oligonucleotide Primers Picornaviridae Proteins Proviruses Puromycin Ribosomes Transcription, Genetic Transfection Vertebral Column Viral Proteins Viral Transcription Virus

Most recents protocols related to «Picornaviridae»

A retrospective ecologic cohort analysis drawing on data from July 1, 2011, to June 30, 2022, in independent, unlinked datasets to visualize and define associations between hepatitis diagnoses in children and virus activity.
The Victorian Agency for Health Information collates, analyses and shares health data from public hospitals across the Australian state of Victoria (population 6.5 million).7 Data are collated under one of 2 main datasets: the Victorian Emergency Minimum Dataset captures emergency department presentations in Victorian public hospitals, and the Victorian Admitted Episodes Dataset (VAED) contains data from Victorian public hospital admissions. Data are stored by ICD-10-AM codes and hepatitis cases were identified using a broad set of relevant codes. We extracted fields related to date of presentation; age (5-year bands); patient area of residence, aggregated to statistical area level 3 (SA3). (“SA3s are designed to provide a regional breakdown of Australia. They generally have a population of between 30,000 and 130,000 people. In regional areas, SA3s represent the area serviced by regional cities that have a population >20,000 people. In the major cities, SA3s represent the area serviced by a major transport and commercial hub. They often closely align to large urban local government areas (eg, Gladstone, Geelong). In outer regional and remote areas, SA3s represent areas that are widely recognized as having a distinct identity and similar social and economic characteristics.”8 )
Monash Health (MH), based in southeast Melbourne, is the largest health network in Victoria, with >210,000 annual pediatric and adult presentations across 3 emergency departments.9 The Royal Children’s Hospital Melbourne (RCH) is the largest children’s hospital in Victoria, with care extending to children from Tasmania, New South Wales and other Australian states. RCH has almost 55,000 admissions annually, with various other non-admission services.1 We obtained respiratory multiplex polymerase chain reaction (PCR) test results during our study period from the 2 pediatric tertiary care hospitals in Victoria. PCR assays reported results for the following viruses: adenovirus, influenza A and B, parainfluenza 1, 2, 3 and 4, SARS-CoV-2, human metapneumovirus (hMPV), respiratory syncytial virus (RSV), parechovirus and picornavirus using commercial multiplex respiratory PCR panels (AusDiagnostics, Syndey, Australia). Data fields included date of test, patient area of residence aggregated to SA3 and PCR test result.
Our inclusion criteria were all respiratory multiplex PCR assays performed at MH and the Royal Children’s Hospital for patients of all ages with a Victorian residential SA3. All hepatitis presentations were included from the VAED, and Victorian Emergency Minimum Dataset between July 1, 2011, and June 30, 2022, if the patient was <19 years old on the day of presentation. Hepatitis A-E cases were excluded, as these cases had an identified viral etiology. Patient records were not available for analysis to ensure patient de-identification.
Publication 2023
Adenoviruses Adult Biological Assay Catabolism Child Diagnosis Emergencies Hepatitis A Hepatitis E Human Metapneumovirus Influenza Inpatient Multiplex Polymerase Chain Reaction Parainfluenza Parechovirus Patients Picornaviridae Polymerase Chain Reaction Respiratory Function Tests Respiratory Rate Respiratory Syncytial Virus SARS-CoV-2 Virus Virus Physiological Phenomena
Mitochondrial membrane potential was detected using mitochondrial membrane potential assay kit (Beyotime, Shanghai, China), according to the manufacturer’s instructions. Briefly, the cells were mock-infected or infected with picornavirus and collected and stained with JC-1 (1:200) at 37°C for 30 min. JC-1 fluorescence was tested at 514–529 nm (green fluorescence, JC-1 monomers) and 585–590 nm (red fluorescence, JC-1 aggregates) using a spectrofluorometer (Thermo Scientific). JC-1 fluorescence images were visualized using a Nikon Eclipse 80i fluorescence microscope. The images were captured using NIS Elements F 2.30 software. The occurrence of JC-1 green fluorescence indicates mitochondrial depolarization.
Full text: Click here
Publication 2023
Biological Assay Cells Fluorescence Membrane Potential, Mitochondrial Microscopy, Fluorescence Mitochondria Picornaviridae
RNA was isolated from samples using the QIAamp Viral RNA kit (Qiagen, Hilden, Germany). Ten μL of undiluted RNA specimen was used as input for first strand synthesis with the Reverta-L RT reagents kit (AmpliSense, Moscow, Russia). Second strand synthesis was performed using Second Strand Synthesis Module (NEB #E611, Ipswich, MA, USA). M220 Focused-ultrasonicator (Covaris, Woburn, MA, USA) was used to fragment DNA to ~550 bp. Paired-end sequencing libraries were constructed with NEBNext® Ultra™ End Repair/dA-Tailing Module (NEB E7546L, Ipswich, MA, USA), NEBNext® Ultra™ Ligation Module (NEB E7595L, Ipswich, MA, USA), Y-shaped adapters compatible with IDT for Illumina Nextera DNA UD Indexes, and NEBNext® Ultra™ II Q5® Master Mix (NEB M0544X, Ipswich, MA, USA), for barcoding PCR, according to the manufacturer’s instructions. The quality and fragment length distribution of the obtained libraries were evaluated with Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). The first several libraries were sequenced on an Illumina MiSeq instrument using v3 600 cycle reagent kit (Illumina, San Diego, CA, USA). The other libraries were sequenced on an Illumina NextSeq 2000 instrument using P2 300 cycle reagent kit (Illumina, San Diego, CA, USA). Sequencing depth varies among samples and highly depends on the quality of a sample and on the sequencing machine used. Since Illumina NextSeq 2000 generates much more data than Illumina MiSeq, samples sequenced on NextSeq have significantly higher sequencing depths. Final output from NextSeq was 9300 Mb per sample on average (31 million paired-end reads) and from MiSeq 1600 Mb per sample (2,7 millions paired-end reads).
To apply the SMART technology to the samples, we decided to use Mint cDNA synthesis kit (Evrogen JSC, Moscow, Russia) with the replacement of the 3′-primer with another specific one. A contig with a low degree of homology to previously known viruses was selected from the 1_N. noctula_miseq_Saratov sample using the BLASTX tool with the Mask low-complexity regions option turned off. This contig was therefore classified as Picornaviridae sp. with E-value equal to 0.0001 and amino acid identity of 29.4%. Only four reads out of 3,704,908 were mapped to this contig. One of these reads (Supplementary Material S1) was selected for primer construction (AAGCAGTGGTATCAACGCAGAGTAC). When mapping the read with BLAST to picornavirus genome, it was detected that it mapped in the reverse orientation to the virus. Picornaviruses possess an RNA genome with positive polarity, so a reverse primer was selected for SMART amplification to reverse-complement the sequence of the read. It was then tailed with a Mint adapter to facilitate its amplification and sequencing. The final sequence of the primer with the adapter was AAGCAGTGGTGGTATCAACGCAGAGAGTAC-AGGTTTGACAATGCAGCAGA.
Next, following the selection of a picornavirus-like read in the metagenomic data and primer construction, we applied the SMART method using a complementary primer and the Mint cDNA synthesis kit (Evrogen, Russia) in accordance with the manufacturer’s guidelines. SMART product sequencing libraries were prepared using the Nextera XT kit. The sequencing was performed on the Illumina MiSeq, utilizing the V2 300 cycle reagent kit.
Full text: Click here
Publication 2023
Amino Acids Anabolism DNA, Complementary Genome Ligation Mentha Metagenome Oligonucleotide Primers Picornaviridae RNA, Viral Virus
DNA encoding a codon-optimized polycistronic peptide consisting of RQR8 and anti-human HER2 (clone 4D5) interspersed with picornavirus T2A and furin cleavage sequences was synthesized by GeneScript. RQR8, used as the transduction marker, is a chimeric surface protein consisting of domains from CD34 (for detection and purification with clone QBEND/10), CD8 (for anchoring at the cell surface) and CD20 (for depletion in vivo with the anti-CD20 monoclonal antibody rituximab)64 (link). shRNA sequences corresponding to the best specificity score for each target were retrieved from the RNAi Consortium library. For coexpression of protein and shRNA, shRNA hairpins were flanked with an optimized sequence of miR-30 (refs. 65 (link),66 (link)). 97-mer oligonucleotides (IDT Ultramers) coding for the respective shRNAs67 (link) were PCR-amplified using 10 µM of the primers miRE-XhoI-fw (5′- TGAACTCGAGAAGGTATATTGCTGTTGACAGTGAGCG-3′) and miRE-EcoRI-rev (5′-TCTCGAATTCTAGCCCCTTGAAGTCCGAGGCAGTAGGC-3′), a 0.5-ng oligonucleotide template and the Q5 High-Fidelity 2X Master Mix (New England Biolabs) and cloned into HER2 CAR vectors containing the miRE scaffold sequence. All coding sequences were cloned into pCDCAR1 (Creative Biolabs). Third-generation lentiviral transfer helper plasmids were obtained from Biocytogen. All sequences are available in Supplementary Table 3.65 (link),67 (link) The following lentiviral vectors purchased from Creative Biolabs were used: a truncated form of epidermal growth factor receptor (vector control) and anti-CD19 CAR with a 4-1BB endodomain.
Full text: Click here
Publication 2023
Cells Chimera Cloning Vectors Codon Cytokinesis Deoxyribonuclease EcoRI DNA Library Epidermal Growth Factor Receptor ERBB2 protein, human Exons Furin Homo sapiens Membrane Proteins ocaratuzumab Oligonucleotide Primers Oligonucleotides Peptides Picornaviridae Plasmids Proteins Rituximab RNA Interference Short Hairpin RNA
The N-terminal Myc/C-terminal Hemagglutinin (HA) double-tagged cGAS was ligated to pcDNA3.1 vector at the sites of HindIII and EcoRI in frame. The N-terminal FLAG/C-terminal HA double-tagged cGAS was ligated to His6-SUMO-pET28a vector at the sites of BamHI and HindIII. N-terminal FLAG tagged 3C proteases of picornaviruses were ligated to pcDNA3.1 or 3×FLAG-CMV-10 vector. The 3C protease of SVV was ligated to His6-SUMO-pET28a vector. Mutant plasmids of cGAS and SVV 3C protease were constructed according to the manufacturer’s instructions of Mut Express II Fast Mutagenesis Kit V2 (Vazyme, #C1002).
Full text: Click here
Publication 2023
3C proteases Chromogranin A Cloning Vectors Deoxyribonuclease EcoRI Endopeptidases Hemagglutinin Mutagenesis Picornaviridae Plasmids Reading Frames

Top products related to «Picornaviridae»

Sourced in Germany, United States, United Kingdom, France, Spain, Japan, China, Netherlands, Italy, Australia, Canada, Switzerland, Belgium
The QIAamp Viral RNA Mini Kit is a laboratory equipment designed for the extraction and purification of viral RNA from various sample types. It utilizes a silica-based membrane technology to efficiently capture and isolate viral RNA, which can then be used for downstream applications such as RT-PCR analysis.
Sourced in United States
PLenti-CMV-GFP-Puro is a lentiviral vector that allows for the expression of GFP (green fluorescent protein) and puromycin resistance in transduced cells. It contains the CMV promoter to drive expression of the transgene.
Sourced in United States, Germany, Japan, China, India, United Kingdom, Switzerland
The ABI 3500 Genetic Analyzer is a capillary electrophoresis instrument designed for DNA sequencing and fragment analysis applications. It utilizes laser-induced fluorescence detection and a 24-capillary array to provide high-throughput analysis of genetic samples.
His-tagged recombinant murine CD19 is a laboratory product that consists of the extracellular domain of the mouse CD19 protein, which is a cell surface receptor expressed on B cells. This protein is produced in a recombinant system and includes a histidine (His) tag for purification and detection purposes.
Sourced in Italy
Flocked nasal swabs are a type of medical device used for the collection of samples from the nasal cavity. They feature a flocked tip designed to efficiently collect and release samples for analysis.
Sourced in France
The EasyMag system is a compact and automated nucleic acid extraction instrument designed for clinical laboratories. It utilizes magnetic separation technology to extract and purify nucleic acids from various sample types. The EasyMag system is capable of processing multiple samples simultaneously, providing efficient and consistent results.
Sourced in United States
The BigDye Terminator Sequencing Kit v1.1 is a DNA sequencing reagent used for Sanger sequencing. It contains fluorescently labeled dideoxynucleotides for detecting DNA sequence information.
Sourced in United States, Germany, Italy, United Kingdom, China, Spain, India, Czechia, Sao Tome and Principe
Neutral red is a synthetic dye commonly used in biological research and laboratory applications. It is a water-soluble, reddish-orange compound that can be used as a pH indicator, a staining agent, and a cell viability assay. The core function of neutral red is to provide a simple and reliable method for visualizing and quantifying living cells in various experimental settings.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, Switzerland, France, Ireland, Finland, Italy, Denmark, Australia, Spain
RNAiMAX is a transfection reagent designed for delivering small interfering RNA (siRNA) or short hairpin RNA (shRNA) into mammalian cells. It facilitates efficient knockdown of target gene expression.
The Immunospot ELISPOT Analyzer is a laboratory instrument used for the detection and quantification of cytokine-secreting cells. It employs the enzyme-linked immunospot (ELISPOT) assay technique to provide an accurate and sensitive measurement of cell-mediated immune responses. The analyzer facilitates the analysis of cells that secrete specific proteins, such as antibodies or cytokines, in response to various stimuli.

More about "Picornaviridae"

Picornaviridae is a diverse family of small, non-enveloped, positive-sense, single-stranded RNA viruses that infect a wide range of host species, including humans, animals, and plants.
This viral family includes well-known pathogens such as poliovirus, rhinovirus, and hepatitis A virus, responsible for diseases like poliomyelitis, the common cold, and hand, foot, and mouth disease.
Understanding the biology and epidemiology of Picornaviridae is crucial for developing effective diagnostic tools, therapies, and preventive measures.
Researchers can leverage the power of PubCompare.ai's AI-driven platform to optimize their Picornaviridae research.
The platform allows users to locate protocols from literature, preprints, and patents, and use AI-powered comparisons to identify the best protocols and products for enhanced reproducibility and streamlined workflows.
For example, the QIAamp Viral RNA Mini Kit can be used for efficient viral RNA extraction, while the PLenti-CMV-GFP-Puro lentiviral vector system can be employed for gene delivery and expression studies.
The ABI 3500 Genetic Analyzer and BigDye Terminator Sequencing Kit v1.1 can be utilized for genetic analysis of Picornaviridae samples.
Flocked nasal swabs and the EasyMag system can be employed for sample collection and nucleic acid purification, respectively.
Neutral red can be used as a viability stain, while RNAiMAX can facilitate RNA interference studies.
The Immunospot ELISPOT Analyzer can be leveraged for immunological assays related to Picornaviridae.
By integrating these resources and tools with the AI-powered capabilities of PubCompare.ai, researchers can streamline their Picornaviridae research workflow, enhance reproducibility, and accelerate the development of effective diagnostic, therapeutic, and preventive strategies.